Oclaro 1470 nm single-emitter laser diodes for skin treatment

These single-emitter laser diodes from Oclaro for skin treatment emit 2 W output power at 1470 nm from a 90 µm stripe, and are available in submount, C-mount or 105 µm fiber-coupled configurations. The fiber-coupled version is built on a proprietary platform for single-emitter fiber laser pump modules.

More Products

-----

PRESS RELEASE

Oclaro Enters Laser-Based Cosmetic Skin Treatment Market with its High-Power Single-Emitter Laser Diodes

Oclaro Continues to Expand Presence in High-Growth Consumer Markets With Cost-Effective and Reliable, High-volume Manufacturing

SAN JOSE, Calif., Jan. 24, 2011 /PRNewswire/ -- Oclaro, Inc. (Nasdaq: OCLR), a tier-one provider of optical communications and laser solutions, today announced that its 1470nm laser diodes, which are selling successfully into the eye-safe laser market, are now being targeted at new high-volume skin treatment consumer markets. The 1470nm single-emitter lasers, which are showcased at the Photonics West show this week, deliver the power, reliability and stable performance necessary in the cosmetic consumer market and Oclaro's manufacturing excellence is bringing this technology down to mainstream price points.

"Oclaro continues to execute on its business strategy to bring proven technology into new high-growth markets that need the economies of scale and expertise that Oclaro can provide," said Yves Le Maitre, Executive Vice President and Division Manager at Oclaro. "Our extensive manufacturing infrastructure enables us to bring cutting-edge laser technology into the hands of consumers, and lasers for cosmetic skin treatment is just one example of the types of markets we can now effectively serve."

About the 1470nm Laser Diodes

New consumer applications in the cosmetic skin treatment market, such as wrinkle reduction, are driving increased demand for cost-effective laser diode solutions.  By leveraging Oclaro's Indium Phosphide technology, that was developed and perfected in the telecom industry, into 1470nm single laser diodes, Oclaro not only delivers the right product set, but it can also scale to volume quickly to meet the price points that are required to be successful in this market. 

The 1470nm single-emitter laser diodes leverage proven Oclaro technology that is currently being used in eye-safe applications in the defense, materials processing and medical markets. The laser diode emits 2W output power at 1470nm from a 90um stripe and is available on a submount, a CMount or in a 105um fiber coupled configuration. The fiber coupled version is built on Oclaro's widely used platform for single emitter fiber laser pump modules and tailored configurations with fast and slow axis lenses for beam confinement address specific high-volume consumer applications. In addition, the laser diodes have demonstrated extreme reliability after being life-tested for more than 5000 hours at 10.5A without any fails.

About Oclaro

Oclaro, Inc. (NASDAQ: OCLR) is a tier-one provider of optical communications and laser components, modules and subsystems for a broad range of diverse markets, including telecommunications, industrial, scientific, consumer electronics, and medical. Oclaro is a global leader, dedicated to photonics innovation with cutting-edge research and development (R&D) and chip fabrication facilities in the U.K., Switzerland and Italy, and in-house and contract manufacturing sites in the U.S., Thailand and China. To support its diverse and global customer base, Oclaro maintains design, sales and service organizations in each of the major regions around the world. For more information visit http://www.oclaro.com.

-----

Posted by Lee Mather

Follow us on Twitter, Facebook, and LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!

POST A COMMENT

Most Popular Articles


BLOGS

Biophotonics trailblazers drive mobile health

The ability of low-cost photonics to enable point-of-care systems is part of the mobile health ma...

NIR-enabled vein viewing gains velocity

There's been a lot of work going on recently to develop commercial vein imaging systems.

Biophotonics leads list of recommendations

Biophotonics is at the top of a prioritized list of seven recommendations put forth last month by...

BioOptics World Archives

View BioOptics World past articles.

Twitter- BioOptics World

Copyright © 2007-2014. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS